Literature DB >> 16961599

Why should statins prevent venous thromboembolism? A systematic literature search and a call for action.

A Squizzato, E Romualdi, W Ageno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16961599     DOI： 10.1111/j.1538-7836.2006.02030.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  5 in total

1.  Venous thromboembolism in patients with membranous nephropathy.

Authors:  Sophia Lionaki; Vimal K Derebail; Susan L Hogan; Sean Barbour; Taewoo Lee; Michelle Hladunewich; Allen Greenwald; Yichun Hu; Caroline E Jennette; J Charles Jennette; Ronald J Falk; Daniel C Cattran; Patrick H Nachman; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

2.  Venous and arterial thrombosis: Two aspects of the same disease?

Authors:  Paolo Prandoni
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

3.  Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).

Authors:  Dilys J Freeman; Michele Robertson; E Ann Brown; Ann Rumley; Edward S Tobias; Marijke Frölich; P Eline Slagboom; J Wouter Jukema; Anton Jm de Craen; Naveed Sattar; Ian Ford; Allan Gaw; Ian A Greer; Gordon D O Lowe; David J Stott
Journal:  BMC Geriatr       Date:  2011-02-22       Impact factor: 3.921

4.  Clinical effects of antiplatelet drugs and statins on D-dimer levels.

Authors:  Suzanne Schol-Gelok; Tom van der Hulle; Joseph S Biedermann; Teun van Gelder; Frederikus A Klok; Liselotte M van der Pol; Jorie Versmissen; Menno V Huisman; Marieke J H A Kruip
Journal:  Eur J Clin Invest       Date:  2018-05-13       Impact factor: 4.686

Review 5.  Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis.

Authors:  Yuhong Mi; Shufeng Yan; Yanhui Lu; Ying Liang; Chunsheng Li
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.